Exploring the Lived Experiences of Community Pharmacists in Deprescribing Practices for Older Adults: A Qualitative Phenomenological Study

Main Article Content

Suriyanti Marasaoly

Abstract

Deprescribing in geriatric pharmaceutical care has emerged as a critical component of patient safety and medication optimization. While existing studies have examined its clinical and procedural aspects, limited research has focused on the lived experiences of community pharmacists who implement deprescribing in daily practice. Despite growing expectations for pharmacists to take an active role, little is known about how they perceive, interpret, and emotionally navigate this responsibility within real-world contexts. This study addresses the question: how do community pharmacists experience deprescribing as part of their professional practice? Using hermeneutic phenomenological interviews with eight community pharmacists in Indonesia, this research explores the ethical, emotional, and relational dimensions of deprescribing from the pharmacists’ perspective. A structured qualitative approach guided the data collection and analysis, allowing for interpretive identification of key experiential themes.  The analysis revealed four core themes: ethical dilemmas in decision-making, clinical uncertainty, interprofessional role negotiation, and emotional labor in patient engagement. These findings highlight the complexity of deprescribing as a deeply human and context-sensitive practice, shaped by professional identity, empathy, and sociocultural values. By illuminating these experiential dimensions, the study contributes a more holistic understanding of deprescribing and underscores the need for supportive frameworks that integrate ethical and emotional considerations into pharmacy practice. The results offer valuable insights for future research and policy development aimed at empowering pharmacists in the deprescribing process.

Article Details

Section

Articles

References

Anderson, K., Foster, M., Freeman, C., Luetsch, K., & Scott, I. (2017). Negotiating “Unmeasurable Harm and Benefit”: Perspectives of GPs and Consultants on Deprescribing in Older Adults. BMJ Open, 7(6), e018203. https://doi.org/10.1136/bmjopen-2017-018203

Galazzi, A., Lusignani, M., Chiarelli, M. T., Mannucci, P. M., & Franchi, C. (2016). Attitudes towards polypharmacy and deprescribing in nursing home residents. Aging Clinical and Experimental Research, 28(4), 731–737. https://doi.org/10.1007/s40520-015-0464-7

Gillespie, R. J., Mullan, J., & Harrison, L. (2020). Deprescribing in the last year of life: A scoping review of the qualitative literature. BMC Geriatrics, 20, 249. https://doi.org/10.1186/s12877-020-01651-z

Hall, S., McLoughlin, R., & Naganathan, V. (2021). Pharmacist-led Deprescribing in Primary Care: A Systematic Review. British Journal of Clinical Pharmacology, 87(9), 3406–3416. https://doi.org/10.1111/bcp.14687

Jokanovic, N., Tan, E. C. K., Dooley, M. J., Kirkpatrick, C. M. J., & Bell, J. S. (2015). Pharmacist Involvement in Medication Review in Residential Aged Care Facilities: A Systematic Review. British Journal of Clinical Pharmacology, 79(4), 566–577. https://doi.org/10.1111/bcp.12519

Kouladjian O'Donnell, L., Gnjidic, D., Sawan, M., & Hilmer, S. N. (2017). Impact of Deprescribing on Mortality and Health Outcomes: A Systematic Review. British Journal of Clinical Pharmacology, 83(8), 1805–1814. https://doi.org/10.1111/bcp.13271

Linsky, A., Simon, S. R., Stolzmann, K., & Meterko, M. (2015). Patient perceptions of deprescribing: Survey development and application in a Veterans Affairs healthcare setting. Research in Social and Administrative Pharmacy, 11(4), 447–458. https://doi.org/10.1016/j.sapharm.2014.09.001

Luymes, C. H., van der Kleij, R. M., Poortvliet, R. K., de Ruijter, W., & Numans, M. E. (2016). Deprescribing potentially inappropriate preventive cardiovascular medication in patients with predicted low cardiovascular benefit: A cluster randomised controlled trial in general practice. BMJ Open, 6(6), e012458. https://doi.org/10.1136/bmjopen-2016-012458

Page, A. T., Potter, K., Clifford, R., Etherton-Beer, C., & Deprescribing Guidelines in the Elderly Project. (2016). Deprescribing in older people. Maturitas, 91, 115–134. https://doi.org/10.1016/j.maturitas.2016.06.006

Reeve, E., & Gnjidic, D. (2022). Deprescribing: A Narrative Review of the Evidence and Practical Recommendations for Recognizing and Overcoming Barriers. Pharmacological Research, 176, 106055. https://doi.org/10.1016/j.phrs.2021.106055

Reeve, E., Low, L. F., & Hilmer, S. N. (2013). Attitudes of older adults and caregivers in Australia toward deprescribing. Journal of the American Geriatrics Society, 61(9), 1508–1514. https://doi.org/10.1111/jgs.12418

Reeve, E., Wiese, M. D., Hendrix, I., Roberts, M. S., & Shakib, S. (2013). People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. Journal of the American Geriatrics Society, 61(9), 1508–1514. https://doi.org/10.1111/jgs.12418

Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., & Jansen, J. (2015). Reducing Inappropriate Polypharmacy: The Process of Deprescribing. JAMA Internal Medicine, 175(5), 827–834. https://doi.org/10.1001/jamainternmed.2015.0324

Thompson, W., Farrell, B., & Morinville, A. (2017). Deprescribing: What is it and what does the evidence tell us? Canadian Journal of Hospital Pharmacy, 70(6), 435–437. https://doi.org/10.4212/cjhp.v70i6.1731

Weir, K. R., Ailabouni, N. J., Schneider, C. R., & Hilmer, S. N. (2021). Pharmacists’ Role in Deprescribing: A Systematic Review of Literature. Research in Social and Administrative Pharmacy, 17(12), 2115–2125. https://doi.org/10.1016/j.sapharm.2021.02.011